Umb Bank, N.A. Ionis Pharmaceuticals Inc Transaction History

Umb Bank, N.A.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Jan 10, 2023	SELL	$37.12 - $46.52 $482 - $604	-13 Reduced 11.4%	101 $4,000
Q3 2022 Oct 13, 2022	SELL	$36.54 - $48.66 $548 - $729	-15 Reduced 11.63%	114 $5,000
Q2 2022 Jul 20, 2022	SELL	$31.71 - $43.0 $412 - $559	-13 Reduced 9.15%	129 $5,000
Q4 2021 Feb 09, 2022	BUY	$25.61 - $35.1 $3,636 - $4,984	142 New	142 $4,000

403

136M

862K

582K

Ticker IONS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 141,940,992
Market Cap $5.35B
Description
Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...

Get notified when there are updates to the investment portfolio of Umb Bank, N.A., based on Form 13F filings with the SEC.

Stay updated on Umb Bank, N.A. with notifications on news.